Coya Therapeutics to Present ALS Biomarker Methodology at NEALS Meeting
Coya Therapeutics plans to present its neurofilament light chain biomarker stratification methodology for the ALSTARS trial at the 2026 Annual NEALS Meeting.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Coya Therapeutics to Present ALS Trial Biomarker Methodology at NEALS Meeting
Coya Therapeutics says it will present its neurofilament light chain biomarker stratification methodology for the ALSTARS trial at the 2026 Annual NEALS Meeting.